ResMed Inc. 2026 Q2 – Results – Earnings Call Presentation (NYSE:RMD) 2026-01-30
Q2: 2026-01-29 Earnings Summary EPS of $2.81 beats by $0.09 | Revenue of $1.42B (10.98% Y/Y) beats by $24.66M This article was written by Follow Seeking Alpha’s transcripts team is responsible for the